Literature DB >> 24768380

The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy.

Alberto Dominguez-Rodriguez1, Pedro Abreu-Gonzalez2, Russel J Reiter3.   

Abstract

Entities:  

Keywords:  Heart failure; Hypertensive cardiomyopathy; Melatonin

Mesh：

Substances：

Year:  2014        PMID： 24768380     DOI： 10.1016/j.ijcard.2014.04.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  16 in total

1.  Rest-activity rhythms, daytime symptoms, and functional performance among people with heart failure.

Authors:  Sangchoon Jeon; Samantha Conley; Nancy S Redeker
Journal:  Chronobiol Int       Date:  2020-06-26       Impact factor: 2.877

2.  Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial.

Authors:  Shervin G Hoseini; Kiyan Heshmat-Ghahdarijani; Saeid Khosrawi; Mohammad Garakyaraghi; Davood Shafie; Marjan Mansourian; Hamidreza Roohafza; Elham Azizi; Masoumeh Sadeghi
Journal:  Clin Cardiol       Date:  2022-02-16       Impact factor: 3.287

3.  ALDH2 contributes to melatonin-induced protection against APP/PS1 mutation-prompted cardiac anomalies through cGAS-STING-TBK1-mediated regulation of mitophagy.

Authors:  Shuyi Wang; Lin Wang; Xing Qin; Subat Turdi; Dongdong Sun; Bruce Culver; Russel J Reiter; Xiaoming Wang; Hao Zhou; Jun Ren
Journal:  Signal Transduct Target Ther       Date:  2020-07-24

4.  Plasma levels of melatonin in dilated cardiomyopathy.

Authors:  Tomofumi Misaka; Akiomi Yoshihisa; Tetsuro Yokokawa; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Yasuchika Takeishi
Journal:  J Pineal Res       Date:  2019-02-26       Impact factor: 13.007

5.  A Peptide-Functionalized Magnetic Nanoplatform-Loaded Melatonin for Targeted Amelioration of Fibrosis in Pressure Overload-Induced Cardiac Hypertrophy.

Authors:  Xueli Zhao; Xuanying Wang; Jing Wang; Jiani Yuan; Juan Zhang; Xiaoli Zhu; Changhui Lei; Qianli Yang; Bo Wang; Feng Cao; Liwen Liu
Journal:  Int J Nanomedicine       Date:  2020-02-27

Review 6.  Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.

Authors:  Mohammad Hossein Pourhanifeh; Ehsan Dehdashtian; Azam Hosseinzadeh; Seyed Hashem Sezavar; Saeed Mehrzadi
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

Review 7.  Effects of melatonin on cardiovascular diseases: progress in the past year.

Authors:  Hang Sun; Aaron M Gusdon; Shen Qu
Journal:  Curr Opin Lipidol       Date:  2016-08       Impact factor: 4.776

Review 8.  Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

Authors:  Zukiswa Jiki; Sandrine Lecour; Frederic Nduhirabandi
Journal:  Front Physiol       Date:  2018-05-17       Impact factor: 4.566

Review 9.  Melatonin in Heart Failure: A Promising Therapeutic Strategy?

Authors:  Frederic Nduhirabandi; Gerald J Maarman
Journal:  Molecules       Date:  2018-07-22       Impact factor: 4.411

10.  The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy.

Authors:  Shouyin Di; Zheng Wang; Wei Hu; Xiaolong Yan; Zhiqiang Ma; Xiaofei Li; Weimiao Li; Jianyuan Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.